60941-77-7 Usage
Uses
Used in Pharmaceutical Synthesis:
8-Azabicyclo[3.2.1]octane-3-methanol, (3-exo)is used as a precursor in the pharmaceutical industry for the synthesis of drugs such as atropine and scopolamine, which are utilized to treat a range of medical conditions due to their ability to block certain receptors in the body.
Used in Therapeutic Research:
In the field of medical research, 8-Azabicyclo[3.2.1]octane-3-methanol, (3-exo)is being investigated for its potential therapeutic properties, including its anticonvulsant and anti-inflammatory effects, which could lead to the development of new treatments for various health issues.
Used in Organic Synthesis:
8-Azabicyclo[3.2.1]octane-3-methanol, (3-exo)is used as a chiral building block in the organic synthesis industry, playing a critical role in the creation of enantiomerically pure compounds, which are essential in the development of pharmaceuticals and other specialty chemicals.
Used in Production of Chemicals and Pharmaceuticals:
In the chemical and pharmaceutical industries, 8-Azabicyclo[3.2.1]octane-3-methanol, (3-exo)serves as a starting material for the production of a variety of chemicals and pharmaceuticals, contributing to the synthesis of complex organic molecules and advancing the development of new products.
Check Digit Verification of cas no
The CAS Registry Mumber 60941-77-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,9,4 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 60941-77:
(7*6)+(6*0)+(5*9)+(4*4)+(3*1)+(2*7)+(1*7)=127
127 % 10 = 7
So 60941-77-7 is a valid CAS Registry Number.
60941-77-7Relevant academic research and scientific papers
CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF
-
Paragraph 0151; 0154, (2019/04/05)
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.
MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
-
Page/Page column 18-19, (2010/02/14)
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.